


Lifetime Clinical Weight Control in Fishers, IN, operates under the clinical direction of Dr. Bart Anderson, DC, who has guided the practice's DNA-based weight loss methodology since its establishment in 2015. The clinic integrates genetic testing with pharmaceutical-grade interventions to address metabolic dysfunction and body composition challenges in patients throughout the Indianapolis metropolitan area. Rather than following standardized diet protocols, the practice analyzes individual genetic markers that influence nutrient metabolism, fat storage patterns, and hormonal responses to create weight management strategies aligned with each patient's biological profile.
The clinic's treatment portfolio centers on semaglutide therapy for appetite regulation and metabolic enhancement, administered within a clinically supervised framework that includes regular body composition analysis and metabolic monitoring. Patients undergo genetic testing that examines variants affecting carbohydrate metabolism, fat oxidation capacity, exercise response, and micronutrient processing—data that informs both nutritional recommendations and pharmaceutical intervention timing. Dr. Anderson's approach combines this genetic intelligence with ongoing body composition assessments using bioelectrical impedance analysis to track lean muscle preservation during weight reduction phases. For patients seeking non-invasive body contouring after weight loss, the practice offers laser treatments targeting localized adipose deposits that resist dietary and pharmaceutical interventions.
Dr. Anderson brings a chiropractic background to metabolic medicine, emphasizing the interconnection between musculoskeletal alignment, nervous system function, and metabolic efficiency. His clinical model requires in-person consultations at the Fishers location, where patients receive initial genetic testing, body composition baseline measurements, and metabolic assessments before beginning semaglutide protocols. The practice structures treatment in phases: genetic analysis and metabolic baseline establishment, pharmaceutical intervention initiation with weekly or biweekly monitoring, nutritional adjustment based on genetic findings, and maintenance programming that includes periodic reassessment of body composition metrics.
Patients at Lifetime Clinical Weight Control follow a supervised protocol that includes regular check-ins to monitor semaglutide response, adjust dosing based on tolerance and results, and modify nutritional strategies as body composition changes. The clinic's genetic testing evaluates polymorphisms in genes such as FTO, MC4R, and PPARG that influence obesity risk and treatment response, providing patients with documentation of their specific genetic factors affecting weight management. Dr. Anderson's team tracks metrics including visceral fat percentage, skeletal muscle mass, basal metabolic rate, and waist-to-hip ratio throughout treatment, using this data to refine both pharmaceutical and nutritional interventions. The practice's laser body contouring option addresses patients who achieve significant weight loss but retain stubborn fat deposits in areas like the abdomen, flanks, or thighs.
Serving Fishers and surrounding Hamilton County communities since 2015, Lifetime Clinical Weight Control requires patients to attend in-person appointments for medication dispensing, body composition analysis, and clinical assessments. The practice does not offer telehealth consultations, maintaining that hands-on metabolic monitoring and body composition measurement provide essential data for optimizing semaglutide protocols and nutritional strategies. Dr. Anderson's DNA-based model distinguishes the clinic from conventional weight loss programs by identifying genetic factors that may explain previous diet failures and predicting which macronutrient ratios and meal timing strategies will produce optimal results for each patient's genetic profile. This combination of genetic science, pharmaceutical intervention, and ongoing clinical supervision has established the practice as a resource for Fishers residents seeking medically managed weight loss grounded in personalized biological data.
Dr. Bart Anderson· DC
Dr. Bart Anderson, DC
Director of Weight Loss Services, Chiropractor
Dr. Bart Anderson is a 1991 graduate of Logan College of Chiropractic in St. Louis, Missouri. After building a successful multi-office network of chiropractic clinics in Indiana, he turned his focus to helping people achieve lasting weight loss through DNA-based approaches.
Leanne Anderson, Butler University Graduate
Weight Loss Coach
Leanne Anderson grew up in Terre Haute and graduated from Butler University in Indianapolis. She has been instrumental in the success of the Activate DNA-Based Weight Loss Program since its launch in 2015, overseeing daily client communication and support.
Topics Mentioned in Reviews
Discovery Package
Full consultation and evaluation, body composition analysis, vibration plate therapy session, red light therapy session
Free Weight Loss Consultation
Free phone consultation with a weight loss coach
Invisa-RED Laser Therapy
Non-invasive laser therapy that emits red light and eliminates fat, boosts metabolism, and tightens skin using near-infrared and infrared laser light energy. 15-minute sessions followed by 10 minutes on whole-body vibration platform.
Body Composition Analysis
Computerized analysis using Tanita technology measuring body fat percentage, muscle mass, body water, bone mass, metabolic age, and visceral fat
Activate DNA-Based Weight Loss Program
Comprehensive program including genetic testing, personalized nutrition plan, natural supplements (Weight Loss, Detox, Energy, Vitality, Digestion), and ongoing support with daily accountability
Red Light Therapy Session
Red light therapy treatment
Vibration Plate Therapy Session
Whole-body vibration platform therapy to stimulate lymphatic system, increase blood flow, and lower cortisol levels
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


